On November 5, 2024 OnKure Therapeutics, Inc. (NASDAQ: OKUR), a clinical-stage biopharmaceutical company focused on the development of novel precision medicines in oncology, reported that Nicholas Saccomano, Ph.D., President and Chief Executive Officer of OnKure Therapeutics, will present a corporate overview at the Stifel Healthcare Conference, on November 18, 2024 at 1:50 p.m. ET in New York, NY (Press release, OnKure Therapeutics, NOV 5, 2024, View Source [SID1234648201]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Stifel Healthcare Conference
Date: Monday, November 18, 2024
Time: 1:50 p.m. ET
Format: Corporate Presentation
Webcast: Link

A live webcast of the event can be accessed under "Events" on the Investor’s section of the Company’s website at www.onkure.com. A replay of the corporate presentation will be available on the Company’s website for approximately 90 days.